Liberty Wealth Management LLC Cytom X Therapeutics, Inc. Transaction History

Liberty Wealth Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$3.87 - $7.39 $1,935 - $3,695	-500 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$6.33 - $9.91 $16,869 - $26,410	-2,665 Reduced 84.2%	500 $3,000
Q2 2021 Aug 13, 2021	BUY	$6.33 - $9.91 $16,869 - $26,410	2,665 Added 533.0%	3,165 $500,000
Q3 2020 Nov 05, 2020	BUY	$6.55 - $8.83 $982 - $1,324	150 Added 42.86%	500 $3,000
Q3 2019 Oct 30, 2019	BUY	$7.38 - $12.25 $2,583 - $4,287	350 New	350 $3,000

50.7M

112K

8.3K

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $79.8M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

Get notified when there are updates to the investment portfolio of Liberty Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Liberty Wealth Management LLC with notifications on news.